English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Epcoritamab Structure 的热门建议
Toripalimab
Structure
Rituximab
Structure
Epcoritamab
Collagen Protein
Structure
Ras Protein
Structure
Starch and Cellulose
Structure
Cytosine
Structure
Glofitamab
Structure
Epcoritamab
IgG
Epcoritamab
Antibody Structure
Epcortimab
Ecoritamab
Epcoritamab
Molecule
Epcoritamab
Folicular
Epcoritamab
Molecular Structure
Organic Molecular
Structure
Epcoritamab
Duo Body Structure
Epicoritamab
Epcoritamab
Genmab
Chemical Molecular
Structure
Epcoritamab
Therapy Diagram
Ofatumumab
Structure
Tinlarebant
Structure
Epcoritamab
Follicular Lymphoma
Epcoritamab
Bispecific
Epcortimab
Syringe
Epcoritamab
Glofitamab Mosunetuzumab
Mosunetuzumab
Structure
Verapamil Chemical
Structure
General MAB Structure
of Epcortimab
T-cell Engager
Structure
Durlobactam
Structure
Epkinly
Structure
Ibogaine
Structure
A Dahlias
Structure
Thearubigins
Structure
Jasmonate
Structure
Afamelanotide
Structure
Azoystrobilin
Structure
Testostérone Chemical
Structure
Abciximab
Structure
Toripalimab Molecular
Structure
Chumash Social
Structure
Odronextamab
Structure
Taletrectinib
Structure
Balsaminaceae
Structure
Epcoritamab
CD3
Bispecific Antibody
Structure
Blinatumomab
Structure
Mass Spectometry for Antibody
Structure
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等(默认)
关闭
筛选器
Toripalimab
Structure
Rituximab
Structure
Epcoritamab
Collagen Protein
Structure
Ras Protein
Structure
Starch and Cellulose
Structure
Cytosine
Structure
Glofitamab
Structure
Epcoritamab
IgG
Epcoritamab
Antibody Structure
Epcortimab
Ecoritamab
Epcoritamab
Molecule
Epcoritamab
Folicular
Epcoritamab
Molecular Structure
Organic Molecular
Structure
Epcoritamab
Duo Body Structure
Epicoritamab
Epcoritamab
Genmab
Chemical Molecular
Structure
Epcoritamab
Therapy Diagram
Ofatumumab
Structure
Tinlarebant
Structure
Epcoritamab
Follicular Lymphoma
Epcoritamab
Bispecific
Epcortimab
Syringe
Epcoritamab
Glofitamab Mosunetuzumab
Mosunetuzumab
Structure
Verapamil Chemical
Structure
General MAB Structure
of Epcortimab
T-cell Engager
Structure
Durlobactam
Structure
Epkinly
Structure
Ibogaine
Structure
A Dahlias
Structure
Thearubigins
Structure
Jasmonate
Structure
Afamelanotide
Structure
Azoystrobilin
Structure
Testostérone Chemical
Structure
Abciximab
Structure
Toripalimab Molecular
Structure
Chumash Social
Structure
Odronextamab
Structure
Taletrectinib
Structure
Balsaminaceae
Structure
Epcoritamab
CD3
Bispecific Antibody
Structure
Blinatumomab
Structure
Mass Spectometry for Antibody
Structure
1125×750
dibesity.com
Epkinly (Epcoritamab-bysp): FDA Approved For Lymphoma
540×540
bloodcancerwa.org.au
Epcoritamab, a Novel, Subcutaneous CD3…
800×500
gelbe-liste.de
Epcoritamab - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
250×250
indianpharmanetwork.in
Epkinly 4 mg/0.8 mL and 48 mg/0.8 mL …
1200×800
pharmtales.com
EPCORITAMAB RECEIVES FDA APPROVAL FOR RELAPSED/R…
1280×960
ajmc.com
New Epcoritamab Data Show Strong Results in B-Cell Lympho…
345×207
targetedonc.com
Subcutaneous Epcoritamab Elicits High Rate of Responses in R/R …
1024×724
creative-biolabs.com
Bispecific Antibody Research Update: Epcoritamab Receives FD…
200×200
onclive.com
Epcoritamab Elicits an ORR of 82% i…
300×300
antibodysociety.org
FDA approves bispecific antibody EPKINLY™ (…
584×294
conferences.medicom-publishers.com
Promising data for epcoritamab plus R-CHOP in untreated DLBCL - Medical ...
2000×1333
hematologyadvisor.com
Epcoritamab Granted Priority Review for Relapsed/Refractor…
2123×1194
pharmaceutical-technology.com
AbbVie's epcoritamab gets one step closer to follicular lymphoma ...
1200×668
journals.lww.com
P1135: SUBCUTANEOUS EPCORITAMAB IN COMBINATION …
480×240
ajmc.com
Subcutaneous Epcoritamab Brings 82% Overall Response in Patients With R ...
508×600
ajmc.com
Subcutaneous Epcoritamab Bring…
2000×1125
empr.com
Epcoritamab Granted Priority Review for Relapsed/Refractory Large B ...
474×307
trendradars.com
Epcoritamab and talquetamab near EMA approval in cancer - TrendRadars
1200×372
journals.lww.com
Subcutaneous Epcoritamab for B-Cell Non-Hodgkin Lymphoma : Oncology Times
2362×1457
pearceip.law
FDA Grants Priority Review of AbbVie’s sBLA for EPKINLY® (e…
850×528
researchgate.net
Epcoritamab mediates comparable levels of cytotoxicity in various B …
500×208
library.ehaweb.org
SUBCUTANEOUS EPCORITAMAB (GEN3013; CD3XCD20) IN PATIENTS …
500×347
library.ehaweb.org
SUBCUTANEOUS EPCORITAMAB IN PATIENT…
500×500
rcsb.org
RCSB PDB - 8U18: Cryo-EM structure …
850×1129
researchgate.net
(PDF) Epcoritamab i…
1847×678
zhuanlan.zhihu.com
epkinly(epcoritamab-bysp)用于弥漫性大B细胞淋巴瘤中文说明书|香港济民药业 - 知乎
818×644
zhuanlan.zhihu.com
Epcoritamab有效率88%,双抗治疗肿瘤时代或将到来 - 知乎
968×370
zhuanlan.zhihu.com
EpCAM靶点调研 - 知乎
GIF
1080×1591
sohu.com
艾伯维和Genmab宣布E…
600×427
zhuanlan.zhihu.com
记住所有FDA生物药 | 靶向CD20 x CD3双抗 | Epcoritamab | 弥漫 …
800×365
xueqiu.com
FDA批准第2款CD3/CD20双抗:艾伯维/Genmab的Epcoritamab Armstrong 2023年…
800×321
xueqiu.com
香港迈极康 | 双特异性抗体Epcoritamab治疗复发/难治性LBCL/DLBCL在美提交上市申请 2022 …
2026×872
nursing.medsci.cn
双特异性抗体 epcoritamab 治疗 LBCL 取得积极结果,包括经 CAR-T 细胞疗法治疗失败的患者 …
721×360
xueqiu.com
CD20 X CD3双特异抗体格局 近日,Genmab和艾伯维宣布其靶向CD20xCD3的双特异抗体epcoritamab(GEN3013)在 ...
1920×1080
zhuanlan.zhihu.com
Epcoritamab有效率88%,双抗治疗肿瘤时代或将到来 - 知乎
某些结果已被隐藏,因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
反馈